Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 11;109(17):1302-1309.
doi: 10.1136/heartjnl-2022-322204.

Propensity-matched analysis of long-term clinical results after ostial circumflex revascularisation

Affiliations

Propensity-matched analysis of long-term clinical results after ostial circumflex revascularisation

Carolina Espejo-Paeres et al. Heart. .

Abstract

Background: Percutaneous coronary intervention (PCI) of the ostium of the left circumflex artery (LCx) is technically challenging. The aim of this study was to compare long-term clinical outcomes of ostial PCI located in the LCx versus the left anterior descending artery (LAD) in a propensity-matched population.

Methods: Consecutive patients with a symptomatic isolated 'de novo' ostial lesion of the LCx or LAD treated with PCI were included. Patients with a stenosis of >40% in the left main (LM) were excluded. A propensity score matching was performed to compare both groups. The primary endpoint was target lesion revascularisation (TLR); other endpoints included target lesion failure and an analysis of the bifurcation angles.

Results: From 2004 to 2018, 287 consecutive patients with LAD (n=240) or LCx (n=47) ostial lesions treated with PCI were analysed. After the adjustment, 47 matched pairs were obtained. The mean age was 72±12 years and 82% were male. The LM-LAD angle was significantly wider than the LM-LCx angle (128°±23° vs 108°±24°, p=0.002). At a median follow-up of 5.5 (IQR 1.5-9.3) years, the rate of TLR was significantly higher in the LCx group (15% vs 2%); with an HR of 7.5, 95% CI 2.1 to 26.4, p<0.001. Interestingly, in the LCx group, TLR-LM occurred in 43% of the TLR cases; meanwhile, no TLR-LM involvement was found in the LAD group.

Conclusions: Isolated ostial LCx PCI was associated with an increase in the rate of TLR compared with ostial LAD PCI at long-term follow-up. Larger studies evaluating the optimal percutaneous approach at this location are needed.

Keywords: acute coronary syndrome; aneurysm, dissecting; atherosclerosis; cardiac catheterization; percutaneous coronary intervention.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Main figure. (A) Example of LAD–LMA angle offline 3D reconstruction (Medis Suite V.3.2.61.0) and angle measurement (150°). (B) Example of LCx–LMA angle offline 3D reconstruction and angle measurement (90°). (C) Boxplot, comparison of angle measurements according to vessel (LAD or LCx). (D) Kaplan-Meier TLR-free survival estimates at 5-year follow-up (LAD vs LCx); log-rank test, p=0.009. *, QFR; #, vessel diameter in millimetre. 3D, three-dimensional; LAD, left anterior descending artery; LCx, left circumflex artery; LMA, left main artery; QFR, quantitative flow ratio; TLR, target lesion revascularisation.
Figure 2
Figure 2
Flowchart. Patients with isolated ostial stenosis located in LAD or LCx detected in coronary angiographies performed between 2004 and 2018. CABG, coronary artery bypass grafting; LAD, left anterior descending artery; LCx, left circumflex artery; PCI, percutaneous coronary intervention.
Figure 3
Figure 3
Different analyses for TLR rates according to subgroups. CKD, chronic kidney disease; IVUS, intravascular ultrasound; LAD, left anterior descending artery; LCx, left circumflex artery; PCI, percutaneous coronary intervention; TLR, target lesion revascularisation.

Similar articles

Cited by

References

    1. Iakovou I, Ge L, Michev I, et al. . Clinical and angiographic outcome after sirolimus-Eluting Stent implantation in Aorto-Ostial lesions. J Am Coll Cardiol 2004;44:967–71. 10.1016/j.jacc.2004.05.058 - DOI - PubMed
    1. Lee W-C, Fang H-Y, Chung W-J, et al. . One-year outcomes following drug-Eluting balloon use for coronary Ostial Restenosis. Int J Cardiol Heart Vasc 2016;10:25–8. 10.1016/j.ijcha.2015.11.003 - DOI - PMC - PubMed
    1. Hsieh I-C, Hsieh M-J, Chang S-H, et al. . Acute and long-term outcomes of Ostial Stentings among bare-metal Stents, sirolimus-Eluting Stents, and paclitaxel-Eluting Stents. Coron Artery Dis 2013;24:224–30. 10.1097/MCA.0b013e32835c8fce - DOI - PubMed
    1. Chin K. An approach to Ostial lesion management. Curr Interv Cardiol Rep 2001;3:87–9. - PubMed
    1. Hoffmann R, Mintz GS, Mehran R, et al. . Intravascular ultrasound predictors of angiographic Restenosis in lesions treated with Palmaz-Schatz Stents. J Am Coll Cardiol 1998;31:43–9. 10.1016/s0735-1097(97)00438-5 - DOI - PubMed